- Home
- AMC vs ANIP Comparison
AMC vs ANIP Comparison
Compare AMC & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMC
- ANIP
- Stock Information
- Founded
- AMC 1920
- ANIP 2001
- Country
- AMC United States
- ANIP United States
- Employees
- AMC N/A
- ANIP N/A
- Industry
- AMC Movies/Entertainment
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- AMC Consumer Discretionary
- ANIP Health Care
- Exchange
- AMC Nasdaq
- ANIP Nasdaq
- Market Cap
- AMC 1.5B
- ANIP 1.2B
- IPO Year
- AMC 2013
- ANIP N/A
- Fundamental
- Price
- AMC $3.50
- ANIP $58.46
- Analyst Decision
- AMC Sell
- ANIP Buy
- Analyst Count
- AMC 5
- ANIP 7
- Target Price
- AMC $4.30
- ANIP $77.33
- AVG Volume (30 Days)
- AMC 13.3M
- ANIP 254.4K
- Earning Date
- AMC 02-26-2025
- ANIP 02-27-2025
- Dividend Yield
- AMC N/A
- ANIP N/A
- EPS Growth
- AMC N/A
- ANIP N/A
- EPS
- AMC N/A
- ANIP N/A
- Revenue
- AMC $4,435,200,000.00
- ANIP $555,456,000.00
- Revenue This Year
- AMC N/A
- ANIP $25.48
- Revenue Next Year
- AMC $11.07
- ANIP $20.24
- P/E Ratio
- AMC N/A
- ANIP N/A
- Revenue Growth
- AMC N/A
- ANIP 23.60
- 52 Week Low
- AMC $2.38
- ANIP $52.50
- 52 Week High
- AMC $11.88
- ANIP $70.81
- Technical
- Relative Strength Index (RSI)
- AMC 34.70
- ANIP 62.05
- Support Level
- AMC $3.21
- ANIP $52.74
- Resistance Level
- AMC $4.13
- ANIP $55.21
- Average True Range (ATR)
- AMC 0.18
- ANIP 1.54
- MACD
- AMC -0.04
- ANIP 0.48
- Stochastic Oscillator
- AMC 31.26
- ANIP 98.11
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, premium presentation. The Company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.